Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors
Ważyńska, M. A., Butera, R., Requesens, M., Plat, A., Zarganes-Tzitzikas, T., Neochoritis, C. G., Plewka, J., Skalniak, L., Kocik-Krol, J., Musielak, B., Magiera-Mularz, K., Rodriguez, I., Blok, S. N., de Bruyn, M., Nijman, H. W., Elsinga, P. H., Holak, T. A. & Dömling, A., 27-Jul-2023, In: Journal of Medicinal Chemistry. 66, 14, p. 9577-9591 15 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
Melo, V., Nelemans, L. C., Vlaming, M., Lourens, H. J., Wiersma, V. R., Bilemjian, V., Huls, G., de Bruyn, M. & Bremer, E., 20-Jul-2023, In: Frontiers in Immunology. 14, 16 p., 1191866.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Prognostic benefit of TILs independent of clinicopathological and molecular factors
Brummel, K., Eerkens, A. L., de Bruyn, M. & Nijman, H. W., 13-Jul-2023, (E-pub ahead of print) In: British Journal of Cancer. 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
-
Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Brummel, K., Eerkens, A. L., de Bruyn, M. & Nijman, H. W., 2-Feb-2023, In: British Journal of Cancer. 128, p. 451–458 8 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile9 Citations (Scopus)10 Downloads (Pure) -
Automated causal inference in application to randomized controlled clinical trials
Wu, J. Q., Horeweg, N., de Bruyn, M., Nout, R. A., Jürgenliemk-Schulz, I. M., Lutgens, L. C. H. W., Jobsen, J. J., van der Steen-Banasik, E. M., Nijman, H. W., Smit, V. T. H. B. M., Bosse, T., Creutzberg, C. L. & Koelzer, V. H., May-2022, In: Nature Machine Intelligence. 4, p. 436–444 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)21 Downloads (Pure)
Activities
- 1 Supervision and examination of PhD students of the UG
-
Tumor immunology and the application of immunotherapy in ovarian carcinoma.
Jon Daniel Laman (Member of PhD Examining Committee), Hans Nijman (Supervisor), An Reyners (Supervisor) & Marco de Bruyn (Co-supervisor)
15-Nov-2021Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
Datasets
-
Supplementary Material for: Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study
Nijman, H. (Contributor), de Bruyn, M. (Contributor), Versluis, M. (Contributor), Van Der Aa, M. A. (Contributor), Hollema, H. (Contributor) & Pielsticker, C. (Contributor), University of Groningen, 1-Jul-2018
DOI: 10.6084/m9.figshare.6322895.v1
Dataset
Press/Media
-
UMCG ontvangt subsidie voor onderzoek naar immuuntherapie bij baarmoederkanker
25/05/2023
1 Media contribution
Press/Media: Research › Popular
-
Onstekingsremmer als mogelijk medicijn bij agressieve kankers
20/06/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Bij agressieve kankers kunnen mogelijk ontstekingsremmers helpen
17/06/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Onstekingsremmer als mogelijk medicijn bij agressieve kankers
15/06/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Immunicum AB Announcements | Immunicum AB: Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer
08/09/2021
1 item of Media coverage
Press/Media: Research › Popular